Dual inhibitors of cholesterol ester and wax ester synthesis for sebaceous gland disorders
CA 2398219 A1 · Owner: Warner-Lambert Company · Inventors: Homan, Reynold
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a method of treating sebaceous gland disorders comprising administering to a patient in need of said treatment an effective amount of a compound named (2,4,6-triisopropyl-phenyl)-acetyl-sulfamic acid 2,6-diisopropyl-phenyl ester or a pharmaceutically acceptable salt thereof. Particularly, methods of treating sebaceous gland disorders are provided wherein said disorders are selected from seborrhea acnes, perioral , dermatitis, rosacea, and corticosteroid-induced acneiform lesions. The present invention provides methods of treating acnes such as for example, chloracne, ciliaris acne, cystic acne keratosa acne, vulgaris acne, senile acne and , medicinal …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 23, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 23, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 23, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.